web statistics
PRESS ROOM        PUBLICATIONS       CAREERS
AboutOur TechnologyCore AreasInvestor Relations & NewsPartneringContact
KineMed  ► Investor Relations & News > Press Room > KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

Forthcoming Events

Latest News

KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

Videos & Webcasts


5980 Horton Street | Suite 470 | Emeryville, CA 94608 | Tel.: USA [1] 510.655.6525 | Fax: [1] 510.655.6506 | TOLL-FREE: 855.KINEMED 

 Copyright © 2014 KineMed, Inc.  |  All Rights Reserved  |  Privacy  |  Terms & Conditions